I know a lot of the Natera focus is treatment decisions. So I'm not sure if part of it might be ici rollover decisions or just stopping or continuing chemo treatments or what.
But I'm guessing they can eventually compare and figure out a whole lot.i haven't looked super closely at each abstract though.
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress https://share.google/pjFevaIwXN4tU0kFn